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Available online 7 June 2016Background:Newcastle disease is an important avian infectious disease that brings about vast economic damage for
poultry industry. Transgenic plants represent a cost-effective system for the production of therapeutic proteins and
are widely used for the production of poultry vaccines. In an attempt to develop a recombinant vaccine, a plant
expression binary vector pBI121, containing the genes encoding Hemagglutinin–Neuraminidase (HN) and Fusion
(F) epitopes of Newcastle Disease Virus (NDV) under the control of CaMV35S promoter and NOS terminator was
constructed and introduced into the tobacco (Nicotiana tabacum) plant by Agrobacterium-mediated transformation.
Results: Putative transgenic plantswere screened in a selectionmediumcontaining 50mg/L kanamycin and 30mg/L
meropenem. Integration of the foreign gene in plant genomewas conﬁrmed by PCR. Expression of foreign genewas
analyzed at transcription level by RT-PCR and at translation level by means of dot blotting and ELISA. All analyses
conﬁrmed the expression of recombinant protein.
Conclusion: Developments in genetic engineering have led to plant-based systems for recombinant vaccine
production. In this research, tobacco plant was used to express F and HN epitopes of NDV. Our results indicate
that for the production of recombinant vaccine, it is a novel strategy to use concatenated epitopes without their
genetic fusion onto larger scaffold structure such as viral coat protein.





Newcastle Disease Virus (NDV) is an economically important
pathogen that infects both wild and domesticated birds [1,2]. NDV
belongs to the Rubulavirus genus and Paramyxoviridae family and is a
negative-sense, single-stranded RNA virus with 15 kb genome. The
genome encodes six major structural and non-structural proteins
including nucleocapsid (NP), phosphoprotein (P), matrix (M), fusion
(F), Hemagglutinin–Neuraminidase (HN) and RNA-dependent RNA
polymerase (L) [3]. F and HN are glycoproteins that are critical for
virulence and these two surface proteins are the most important targets
for the host immune response and induce neutralizing antibody against
NDV [3]. Amino acids 65–81 of F protein and 346–353 of HN have been
identiﬁed as the most important immunogenic sites for antibodyiari), abagheri@um.ac.ir
idad Católica de Valparaíso.
araíso. Production and hosting by Elinduction [4]. Killed or attenuated viruses are currently used as
anti–NDV vaccine [4]. Although these vaccines are effective, high cost of
vaccination, side effects such as egg decrease in chickens, high labor cost
and stress that may lead to a reduction in egg-laying, or to an increased
susceptibility to microorganisms infections call for a new method of
production of NDV vaccines [4]. The best route of vaccination against
NDV is oral administration as vaccines can be incorporated in poultry
diet [5]. Production of recombinant vaccines based on capsid subunits
and their application as oral vaccines is an effective alternative for
conventional attenuated virus-based vaccines [6].
Plants represent an ideal platform for the production of recombinant
vaccines [7]. Transgenic plants expressing foreign proteins of industrial
and therapeutic value are good alternatives for fermentation systems.
Various vaccines expressed transiently or permanently in green plants
showed accurate conformation for the induction of protective and
neutralizing immune responses in human, animal and poultry [7]. A
major advantage of plant-based recombinant vaccines — in addition to
ease of production and administration — is the induction of mucosal
immunity which subsequently results in high immunity for the host.
Considering that oral or nasal vaccine — delivery is more effective atsevier B.V. All rights reserved.
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antigens in plants to be delivered as edible vaccines [7]. The successful
use of transgenic plants for the expression of a number of pathogen
antigens has revealed new prospects for vaccine production [8,9].
Due to numerous advantages, tobacco is widely used in genetic
transformation as a plant host. Advantages include ease of
transformation, availability of optimized tissue culture systems and
high level of transgene expression [10]. Thus, this plant species is
commonly used in scientiﬁc research as a plant host and when
successful, the gene of interest can be transferred into other plants
[10,11].
The present study aims to transfer and express F and HN epitopes in
tobacco. Since tobacco is an ideal model plant for transgene expression,
the successful expression of the epitopes in this plant can be the
beginning for the commercial production of recombinant anti-NDV
vaccines in other plant species.
2. Materials and methods
2.1. Designing gene construct
Four tandem repeats of HNepitope (encoding amino acids 346–353)
with 96 bp length followed by three tandem repeats of F epitope
(encoding amino acids 65–81) with 153 bp length were used. The
sequences were retrieved from NCBI. The gene was codon optimized
to ensure high level of expression. The initiation codon (AUG)
followed by histidine tag (18 bp) and omega sequence as ribosome
binding (67 bp) site were attached in upstream of the gene. The
endoplasmic reticulum signal (SEKDEL) was included to 3′ end just
before termination codon. Finally, two restriction sites namely BamHI
and SacI were added to 5′ and 3′ ends. The ﬁnal length of the gene
was 376 bp. Gene was designed by CLC software (Fig. 1). The resulting
gene construct was synthesized and cloned in pGH vector by Gene ray
Company.
2.2. Construction of pBI121 construct containing F and HN antigens
Gene construct was removed from pGH via digestion by BamHI and
SacI; binary vector pBI121 containing CaMV 35S promoter and NOS
terminator was digested by the same enzymes and after removingFig. 1. Gene construct including F and HN epitopes togethGUS sequence, gene construct of F and HN epitopes was inserted
between promoter and terminator (Fig. 2). The resulting construct is
called pBI121-NDV epitopes which was transferred to agrobacterium
using electroporation. To conﬁrm the presence of the plasmid within
bacterial cell after extraction and digestion by HindIII, a fragment of
about 1096 bp was revealed on electrophoresis gel (Fig. 3).
2.3. Agrobacterium-mediated transformation of tobacco
Agrobacterium tumefaciens strain C58 harboring pBI121-NDV
epitopes was cultured in LB medium for 18 h. The bacterial suspension
at OD600 = 0.6 was centrifuged at 3500 × g for 20 min. Bacterial pellet
was cultured for 120 min at 28°C in transformation medium (MS salts,
5% glucose and 200 μM acetosyringone, pH = 7.5).
Leaf disc method was applied to transform tobacco plant. Brieﬂy,
surface sterilized leaf discs of Nicotiana tabacum cv. Turkish were
co-cultivated with A. tumefaciens suspension carrying pBI121-NDV
epitopes plasmid for 15 min, then transferred into MS medium
containing 2 mg/L BA and 2 mg/L NAA and incubated in darkness. After
48 h, the discs were washed with 30 mg/L meropenem to eliminate
agrobacterium. The explants were then transferred to regeneration
medium containing MS salts, 2 mg/L BA, 2 mg/L NAA, 50 mg/L
kanamycin and 30 mg/L meropenem at 25°C and photoperiod of 16 h
light/8 h darkness. Subculture was done every two weeks and for
rooting of the explants, the regenerated plantlets were cultured in root
induction medium (MS containing 2 mg/L IBA).
2.4. DNA extraction and PCR
To determine the presence of foreign gene in genome of the
regenerated seedlings resistant to kanamycin, genomic DNA was
extracted from young leaves of the seedlings and from wild type plants
using the method proposed by Dellaporta et al. [12]. PCR was
performed by speciﬁc primers with sequences of 5′TCATTGCGATAAAG
GAAAGGC3′ and 5′AATGTATAATTGCGGGACTC3′. PCR was carried out
by 35 cycles of 94°C for 60 s, 54°C for 60 s and 72°C for 60 s, followed
by a ﬁnal extension step of 72°C for 10 min. DNAs of wild type plant
and plasmid pBI121-NDV epitopes were used as negative and positive
control; respectively. PCR product was segregated on 1% agarose gel.er with needed sequences for expression in tobacco.
Fig. 2. Schematic structure of the recombinant plasmid pBI121-NDV epitopes for Agrobacterium-mediated transformation of tobacco plant. The DNA sequence encoding NDV epitopewas
cloned the downstream of the CaMV 35S promoter of a binary plasmid pBI 121.
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2.5.1. Assessing expression at transcription level using RT-PCR
Total RNA was extracted using Dena Zist commercial kit. After
treatment with DNAse, cDNA was synthesized by cDNA synthesis Kit,
Thermo Fisher Scientiﬁc. PCR was performed by speciﬁc primers
(forward: 5′ACTATTTACAATTACAATGCATCAC3′; reverse: 5′GAGTTCAT
CCTTTTCAGAAAGTG3′) to verify transgene expression. PCR cycles
comprised denaturation at 94°C for 1 min, annealing at 55°C for 45 s,
and extension at 72°C for 45 s. cDNA of wild type plant and
pBI121-NDV epitopes plasmid were used as negative and positive
controls.2.5.2. Assessing expression at translation level using dot blotting
After extraction of total protein from transgenic and wild type
plants, dot blot analysis was conducted. Protein samples were dottedFig. 3. Digestion of pBI 121-NDV epitopes plasmid extracted from A. tumefaciens by Hind
III, 1: 100 bp ladder; 2: digested plasmid.on the membrane and the membrane allowed to get dried at 37°C.
The membrane was incubated with BSA as blocking solution for 1 h.
the membrane was then incubated with anti-His-tag conjugated with
Hrp (diluted in BSA at 1:1000) at 37°C. The membrane was washed
three times with PBS/PBST and then incubated with TMB substrate.
Three microliters of wild type protein was used as negative control.
2.5.3. Quantiﬁcation of recombinant protein by indirect ELISA
Total soluble proteins were extracted from fresh leaves using
pre-chilled phosphate-buffered saline (PBS, pH 7.2) with 5 mMEDTA
and 0.001% PMSF (phenyl methlysulforyl ﬂuoride). Approximately 0.5 g
fresh leaves was ground to ﬁne powder in a pre-cooled mortar and two
volumes of ice-cold extraction PBS were added. The homogenate was
centrifuged at 14,000 × g for 15 min at 4°C. The supernatant obtained
was used for ELISA analysis.
The 96-well plate was coated with total soluble proteins (TSP) from
the wild type and the transformed plant and puriﬁed NDV particles
(commercial vaccine) at 37°C for 1 h; followed by incubation with 1%
bovine serum albumin (BSA) in PBS for 2 h at 37°C to prevent
non-speciﬁc binding. The wells were washed by PBST/PBS and
incubated with anti-NDV serum and then horseradish peroxidase
conjugated with anti-rabbit IgG (1:1500). The anti-NDV serum was
prepared after three times of immunization in rabbit with the
inactivated V4 NDV particles and diluted at 1:1000 in PBST.
Wells were developed with TMB substrate; the color reaction was
stopped by 2N H2SO4 and read at 450 nm of wavelength. The OD450
nm value of samples was compared with that of known concentration
of puriﬁed NDV particles to estimate the relative quantity of
recombinant protein expressed in transgenic tobacco plant.
3. Results
In this research, transgenic tobaccowas generated via co-culture with
A. tumefaciens containing pBI121-NDV epitopes plasmid in a selection
medium supplemented with 50 mg/L kanamycin and 30 mg/L
meropenem (Fig. 4). PCR primers were designed so that forward
attaches CaMV35S promoter and reverse primer attaches NOS sequence
producing a 180 bp band. The band was observed in a transgenic plant
and positive control and was not seen in wild type plant suggesting lack
of transgene in its genome (Fig. 5). Expression of F and HN epitopes
were evaluated at transcription level by RT-PCR using three samples of
transgenic plant. Results showed that transgene was expressed in all the
samples (Fig. 6). Production of recombinant protein was evaluated in
the samples that had shown positive results in RT-PCR. Dot blot
conﬁrmed production of recombinant proteins in all the transgenic
plants which was measured by intensity of blotting signal; whereas it
was not expressed in wild type plant (Fig. 7). ELISA analysis was carried
out to detect the antigen in total soluble proteins from leaves of
transgenic plant and wild types. The results showed that there was
immune reactivity with the NDV antibodies in transgenic plant, as the
measured OD450 nm value was signiﬁcantly higher (5% level of
signiﬁcance) than that in the untransformed wild type implying that
the transgene was expressed in the transgenic tobacco (Fig. 8).
Fig. 4. Regeneration of transgenic tobacco plants in selection medium containing 50mg/L
kanamycin and 30 mg/L meropenem.
Fig. 6. Evaluation of expression at transcription level using RT-PCR and ampliﬁcation of
307 bp fragment: 100 bp marker (1); wild type plant as negative control (2); transgenic
plant (3–5); NDV epitopes-PBI 121 plasmid as positive control.
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and speciﬁc anti-NDV antibody, the relative quantity of expressed
recombinant protein was estimated, and it was observed that
concentration of foreign protein in the plant tissue was 0.44% TSP (data
not shown). In all, these results demonstrate the speciﬁc presence and
expression of transgene under the control of CaMV 35S promoter in
transformed tobacco plants.
4. Discussion
Application of green plants for the production of recombinant protein
is an attractive alternative for the development of new generation
vaccines. The production of therapeutic proteins including recombinant
vaccines in plants represents an economical alternative to bothFig. 5. Evaluation of foreign gene in transgenic tobacco by PCR and ampliﬁcation of 810 bp frag
plasmid and Agrobacterium containing this plasmid as positive control (3–4); transgenic plantstraditional inactivation of infectious agents and fermentation-based
expression systems, especially in the production of high-volume
reserves of subunit vaccines. Genetic engineering of higher plants was a
turning point in the ﬁeld of recombinant vaccine production. The goal is
to produce transgenic plants that upon oral or parenteral administration
induce an immune response in the body. Many authors have reported
that antibody is produced in response to the antigens produced in plant
and administered orally or by injection [8,13,14,15]. The results of
researchers reporting immunogenicity of viral antigens expressed in
transgenic plants encourage the study of expression of other viral
antigens in plants. In the studies of plants as bioreactor, tobacco is the
most preferred model to express foreign proteins because of its ease of
transformation and fast regeneration.
In the present paper, a synthetic gene including 4 tandem repeats of
HN epitopes and 3F epitopes of NDV was prepared. This construct was
optimized based on tobacco preferred codons according to studies
reporting that codon optimization can elevate quality and quantity of
protein [6,16]. 5′ leader sequence of tobacco mosaic virus (TMV) called
omega which is regarded as a translation enhancing element was added
to 5′UTR [17]. Regarding the effect of SEKDEL on enhancement of gene
expression [18], SEKDEL was attached to 3′ end just before the stop
codon. Histidine tag was added to amino terminal of the gene for
identiﬁcation and isolation of target protein using anti-His sequence.
The results indicated that the strategies used for enhancing gene
expression were successful.
After regeneration of transgenic seedlings, total DNAwas extracted to
screen for the foreign gene using PCR. PCR primers were designed so that
they matched the promoter and terminator of pBI121 yielding a band of
810 kb length. PCR results showed that 62% of the seedlings werement: 100 bp marker (1); wild type plant as negative control (2); NDV epitopes-PBI 121
(5–12).
Fig. 7. Assessing expression at translation level using dot blotting: negative control (1); transgenic plant (2–4).
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measured in three plants using RT-PCR and Dot blot with the results
showing that the sharpness of RNA band is positively related to protein
quantity (Fig. 6 and Fig. 7). This ﬁnding is in accordance with those
reported by Lai et al. [9]. These authors provided scientiﬁc evidence on
the correlation between RNA band sharpness and protein level.
Moreover, the expression of recombinant protein was detected by anti
NDV serum in ELISA tests. The levels of recombinant protein obtained
were in accordance with those reported by other researchers [3,8].
It was shown in this research that synthetic protein includes
numerous repeats of F and HN epitopes in tobacco. The results indicated
that it is an interesting and novel strategy to use the concatenated
epitopes without their genetic fusion to larger scaffold structure such as
viral coat protein.
Application of green plants for the production of recombinant
vaccines is of great importance. Considering recent developments in
genetic engineering and transformation methods, it is possible to
develop a wide range of transgenic plants that can express various
recombinant pharmaceutical compounds including viral and bacterial
antigens, antibodies, and many other therapeutic proteins. However, the
low expression level of foreign antigens represents a major hurdle for
commercialization of recombinant subunit vaccine production. This
limitation has been reported by many authors as a main barrier to the
widespread use of plant-based platforms as bioreactors in commercial
production of recombinant vaccines. Therefore, it can be concluded that
improving the expression level of recombinant vaccines in plant cells is
an important step towards practical use of recombinant vaccine
technology. To address this problem, we applied an integrated approach
including codon optimization, inclusion of omega leader sequence and
an endoplasmic reticulum signal peptide (SEKDEL) to enhance
expression of the antigen in transgenic plants.
The results of this research conﬁrm the efﬁcacy of
Agrobacterium-mediated transformation for the production ofFig. 8. ELISA analysis of NDV epitope expression in leaves of transgenic plant (p b 0.05).
Each data represents an average value ± S.D. from three samples.recombinant vaccine. This approach is still the ﬁrst choice for
recombinant protein production compared to other methods. For
example, in an attempt to produce anti-NDV vaccine using viral vectors,
the authors observed that duplication of the HN epitope rendered the
virus non-viable [19]. However, in the present study, insertion of four
tandem repeats of HN epitope with 96 bp length followed by three
tandem repeats of F epitope with 153 bp did not interfere with foreign
gene expression. We believe that our results provide additional support
to the feasibility of using transgenic plants as an effective system for the
production of recombinant vaccines.
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